Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.

@article{Guerdjikova2012DuloxetineIT,
  title={Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.},
  author={Anna I Guerdjikova and Susan L McElroy and Erin L. Winstanley and Eric B. Nelson and Nicole Mori and Jessica McCoy and Paul E. Keck and James I. Hudson},
  journal={The International journal of eating disorders},
  year={2012},
  volume={45 2},
  pages={281-9}
}
OBJECTIVE This study evaluated duloxetine in the treatment of binge eating disorder (BED) with comorbid current depressive disorders. METHOD In this 12-week, double-blind, placebo-controlled trial, 40 patients with Diagnostic and Statistical Manual of Mental Disorders-IV-TR BED and a comorbid current depressive disorder received duloxetine (N = 20) or placebo (N = 20). The primary outcome measure was weekly binge eating day frequency. RESULTS In the primary analysis, duloxetine (mean 78.7… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…